+ All Categories
Home > Documents > Guidelines on ACS-NSTE (TF21) - Task Force Members and ... · Agewall Stefan Yes A - Direct...

Guidelines on ACS-NSTE (TF21) - Task Force Members and ... · Agewall Stefan Yes A - Direct...

Date post: 14-Sep-2019
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
24
Agewall Stefan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Platelet inhibition Bassand Jean-Pierre Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Glaxo Smith Kline : fondaparinux - Lilly : prasugrel - Astra Zeneca : ticagrelor Bax Jeroen Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Heart.org : Education - Astra Zeneca : Farma - Servier : Farma - Philips : Imaging - GE Healthcare : Imaging - Lantheus : Imaging - Boston Scientific : Pacing - Medtronic : Pacing - St Jude Medical : Pacing - Biotronik : Pacing - Impulse Dynamics : Pacing D - Research funding (departmental or institutional). - Servier : Farma - Edwards Lifesciences : Heart Valves - GE Healthcare : Imaging - Lantheus : Imaging - Boston Scientific : Pacing - Medtronic : Pacing - St Jude Medical : Pacing Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors Expert Relationship with Industry Type of relationship with industry Financial declaration
Transcript

Agewall Stefan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Platelet inhibition

Bassand Jean-Pierre Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Glaxo Smith Kline : fondaparinux - Lilly : prasugrel

- Astra Zeneca : ticagrelor

Bax Jeroen Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Heart.org : Education - Astra Zeneca : Farma

- Servier : Farma

- Philips : Imaging

- GE Healthcare : Imaging

- Lantheus : Imaging

- Boston Scientific : Pacing

- Medtronic : Pacing

- St Jude Medical : Pacing

- Biotronik : Pacing

- Impulse Dynamics : Pacing

D - Research funding (departmental or institutional). - Servier : Farma - Edwards Lifesciences : Heart Valves

- GE Healthcare : Imaging

- Lantheus : Imaging

- Boston Scientific : Pacing

- Medtronic : Pacing

- St Jude Medical : Pacing

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Bax Jeroen Yes - Biotronik : Pacing

Boersma Eric Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : coronary artery disease

Bueno Hector Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer Healthcare : Aspirin - Merck, Schering Plough : None

- Daiichi Sankyo : Prasugrel

- Eli Lilly : Prasugrel

- Astra Zeneca : Ticagrelor

Caso Pio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Consorzio formazione medica : lessons C - Receipt of royalties for intellectual property. - piccin nuova libraria spa : book

Dudek Dariusz Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boehringer-Ingelheim : speaker fee, advisory boards, investigator. - Boston Scientific : speaker fee, advisory boards, investigator.

- Eli Lilly : speaker fee, advisory boards, investigator.

- Pfizer : speaker fee, advisory boards, investigator.

- Sanofi Aventis : speaker fee, advisory boards, investigator.

- Siemens Healthcare : speaker fee, advisory boards, investigator.

- GlaxoSmithKline : speaker fee, advisory boards, investigator.

- Bayer Healthcare : speaker fee, advisory boards, investigator.

- Cook Medical : speaker fee, advisory boards, investigator.

- Medicines Company : speaker fee, advisory boards, investigator.

- Nycomed : speaker fee, advisory boards, investigator.

- Bristol Myers Squibb : speaker fee, advisory boards, investigator.

- MSD : speaker fee, advisory boards, investigator.

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Dudek Dariusz Yes - Balton : speaker fee, advisory boards, investigator.

- Cordis : speaker fee, advisory boards, investigator.

- Biotronic : speaker fee, advisory boards, investigator.

- Solvay : speaker fee, advisory boards, investigator.

- BBraun : speaker fee, advisory boards, investigator.

- EuroCor : speaker fee, advisory boards, investigator.

- INvatec : speaker fee, advisory boards, investigator.

- Medtor : speaker fee, advisory boards, investigator.

- Promed : speaker fee, advisory boards, investigator.

- Therumo : speaker fee, advisory boards, investigator.

- Tyco : speaker fee, advisory boards, investigator.

E - Research funding (personal). - Abbott : speaker fee, advisory boards, investigator. - Adamed : speaker fee, advisory boards, investigator.

- Astra Zeneca : speaker fee, advisory boards, investigator.

- Boehringer-Ingelheim : speaker fee, advisory boards, investigator.

- Boston Scientific : speaker fee, advisory boards, investigator.

- Eli Lilly : speaker fee, advisory boards, investigator.

- Medtronic : speaker fee, advisory boards, investigator.

- Pfizer : speaker fee, advisory boards, investigator.

- Biotronik : speaker fee, advisory boards, investigator.

- Terumo Inc : speaker fee, advisory boards, investigator.

- Sanofi Aventis : speaker fee, advisory boards, investigator.

- Siemens Healthcare : speaker fee, advisory boards, investigator.

- GlaxoSmithKline : speaker fee, advisory boards, investigator.

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Dudek Dariusz Yes - Bayer Healthcare : speaker fee, advisory boards, investigator.

- Cook Medical : speaker fee, advisory boards, investigator.

- Nycomed : speaker fee, advisory boards, investigator.

- MSD : speaker fee, advisory boards, investigator.

- Balton : speaker fee, advisory boards, investigator.

- Cordis : speaker fee, advisory boards, investigator.

- Solvay : speaker fee, advisory boards, investigator.

- BBraun : speaker fee, advisory boards, investigator.

- EuroCor : speaker fee, advisory boards, investigator.

- INvatec : speaker fee, advisory boards, investigator.

- Promed : speaker fee, advisory boards, investigator.

- Tyco : speaker fee, advisory boards, investigator.

- Biomatrix : speaker fee, advisory boards, investigator.

- Mediciine Company : speaker fee, advisory boards, investigator.

Gielen Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Genzyme : Lecture on genetic cardiac diseases incl. M. Fabry, 1000 € honorarium - Astra zeneca, boheringer, menarini : Product-independent cardiology case workshop twice a year, honorarium 1.100 € per event

Hamm Christian Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck : drugs - Pfizer : drugs

- Sanofi-Aventis : drugs

- The Medicines Company : drugs

- Menarini : drugs

- Daiichi-Sankyo : drugs

- Berlin Chemie AG : drugs

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Hamm Christian Yes - Heart.org : drugs

- Boehringer Ingelheim - Ingelheim; Daiichi-Sankyo/Eli Lilly; Nycomed Pharma : drugs

- Takeda Pharmaceuticals : drugs

- Glaxo Smith Kline : drugs

- Astra Zeneca, Bayer AG, Boehringer-Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, Sanofi-Aventis, Servier : drugs

- BRAHMS GmbH : markers

- Siemens Healthcare : MRI

- Boston Scientific : PCI

- Cordis and Medtronic : PCI

Huber Kurt Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : atorvastatin - The Medicines Company - speakers fees : bivalirudin; cangrelor

- BRAHMS GmbH - speakers fees : copeptin assay

- Boehringer Ingelheim - speakres fees; advisory board fees (dabigatran) : dabigatran

- Boston Scientific - speakres fees : none

- Biotronik - speakers fees : none

- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : prasugrel; abciximab

- Bayer - speaker fees; advisory board fees (rivaroxaban) : rivaroxaban

- Astra Zeneca - speakers fees; advisory board fees (ticagrelor) : ticagrelor; rosuvastatin

Ohman E Magnus Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Liposcience : Diagnostic tests - WebMD : Online health information provider

- Astra Zeneca : Pharmaceuticals

- Boehringer-Ingelheim : Pharmaceuticals

- The Medicines Company : Pharmaceuticals

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Ohman E Magnus Yes - Sanofi Aventis : Pharmaceuticals

- Bristol Myers Squibb : Pharmaceuticals

- Merck Sharp & Dohme : Pharmaceuticals

- Gilead Sciences : Pharmaceuticals

- Pozen, Inc. : Pharmaceuticals

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Pharmaceuticals - Eli Lilly : Pharmaceuticals

D - Research funding (departmental or institutional). - Maquet : Medical technology/products - Daiichi Sankyo : Pharmaceuticals

- Eli Lilly : Pharmaceuticals

Petrie Mark Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Roche : diabetes - GSK : diabetes

- Astellas : diabetes

- Servier : heart failure

Sonntag Frank Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : CAD - Sanofii-Aventis : CAD

- Bayer Healthcare : CAD

- Merck Sharp & Dome : CAD

- Boehringer Ingelheim - : CAD

- Astra Zeneca : CAD,Plateletaggregationinhibitor

Sousa Uva Miguel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Medtronic : TAVI

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Sousa Uva Miguel Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Antiplatelet agent

Storey Robert Frederick Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Cangrelor - Sanofi Aventis : Clopidogrel

- Bristol Myers Squibb : Clopidogrel

- Novartis : Elinogrel

- GlaxoSmithKline : Fondaparinux

- Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Prasugrel

- Astra Zeneca : Ticagrelor

- Merck : Vorapaxar

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Ticagrelor - Accumetrics : VerifyNow

D - Research funding (departmental or institutional). - Daiichi Sankyo : Prasugrel - Eli Lilly : Prasugrel

- Astra Zeneca : Ticagrelor

- Merck : Vorapaxar

Wijns William Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : device - Edwards Lifesciences : device

- Terumo Inc : device

- Cordis : device

- Orbus Neich : device

- Astra Zeneca : drug

Guidelines on ACS-NSTE (TF21) - Task Force Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Wijns William Yes - Eli Lilly : drug

- GlaxoSmithKline : drug

- Bristol Myers Squibb : drug

D - Research funding (departmental or institutional). - Cardio3 Biosciences : cell therapy - Boston Scientific : device

- Medtronic : device

- St Jude Medical : device

- Abbott Laboratories : device

- Biotronic : device

- Therabel : drug

- Ablynx : nano antibodies

Zahger Doron Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Sanofi Aventis : Dronedarone - Pfizer : lipitor

- Eli Lilly : prasugrel

- Astra zeneca, boheringer, menarini : Ticagrelor

Guidelines on ACS-NSTE (TF21) - TF Members and Additional Contributors

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Achenbach Stephan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Siemens Healthcare : CT - Servier : Imaging

- Guerbet : Imaging

D - Research funding (departmental or institutional). - Siemens Healthcare : Imaging - Bayer Healthcare : Imaging

Badimon Lina Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : cardiovascular - Menarini : cardiovascular

- Esteve : Cardiovascular

Bertrand Michel Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Lilly : Anticoagulants - Servier International : Antihypertensive drugs. Antiischemic drugs

Botker Hans Erik Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fee : Hyperlipidema, angina pectoris

Collet Jean-Philippe Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bristol Myers Squibb : apixaban - Nycomed : aspirin

- Sanofi Aventis : clopidogrel

- Roche Diagnostics : hypersensitive troponin

- Astra Zeneca : prasugrel

- Eli Lilly : prasugrel

D - Research funding (departmental or institutional). - Sanofi-Aventis : clopidogrel - Cordis and Medtronic : platelet function testing

Crea Filippo Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Pfizer - speakers fees : Atorvastatin

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Crea Filippo Yes - Boehringer Ingelheim-Advisory Board : Dabigatran

- GSK : Darapladip

- Sanofi Aventis - speaker fee : Prasugrel

- Astra Zeneca - speaker fee : Rosuvastatin

- Chiesi - speaker fees : Rosuvastatin

D - Research funding (departmental or institutional). - Pfizer : Atorvastatin - Sanofi Aventis : Prasugrel

- Chiesi - speaker fees : Rosuvastatin

Danchin Nicolas Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : antianginal agents - The Medicines Company : Antithrombotic agents

- BMS/Pfizer : Antithrombotic agents

- Boehringer Ingelheim : Antithrombotic agents

- Daiichi Sankyo, Eli-Lilly : Antithrombotic agents

- Sanofi-Aventis : antithrombotic agents, antiarrhythmic agents

- Astra-Zeneca : Antithrombotic agents, statins

- Novo-Nordisk : Diabetes

- Pierre Fabre : Omega 3

D - Research funding (departmental or institutional). - Merck : Myocardial infarction - Sanofi-Aventis : Myocardial infarction

- The Medicines Company : Myocardial infarction

- GSK : Myocardial infarction

- Astra-Zeneca : Myocardial infarction

- Daiichi-Sankyo Eli Lilly : Myocardial infarction

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Falk Erling No

Goudevenos John A No

Gulba Dietrich Cl Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : Bivalirudin - Boehringer-Ingelheim : Dabigatran, rt-PA, TNK-tPA

- Sanofi Aventis : Enoxaparin

- Daiichi Sankyo : Prasugrel

- Eli Lilly : Prasugrel, abciximab

- Bayer Healthcare : Rivaroxaban

- Astra Zeneca : Ticagrelor

Hambrecht Rainer Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Berlin Chemie : ranolazine B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - pohl boskamp : nitrates

Herrmann Joerg No

Kastrati Adnan Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott - lecture fees : DES B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : Antiplatelet - Lilly : Antiplatelet

- Biosensors : DES

- Cordis : DES

- Biotronic : DES

Kjeldsen Keld Per No

Kristensen Steen Dalby Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo : Antithrombotics - Eli Lilly : Antithrombotics

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Kristensen Steen Dalby Yes - Merck : Antithrombotics

- The Medicines Company : Antithrombotics

- AstraZeneca : Antithrombotics

Lancellotti Patrizio Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - ,astra zeneca, boheringer, menarini : pradaxa, belsar, crestor B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Actelion : tracleer

Mehilli Julinda Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Daiichi Sankyo - speaker fee : Antithrombotic drugs - Abbott - lecture fees : Stents

D - Research funding (departmental or institutional). - Abbott : Unrestricted grant for clinical studies - Terumo : Unrestricted grant for clinical studies

Merkely Bela Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Biotronik, Boston Sci, Medtronic, Sanofi-Aventis, Servier, St. Jude : CRT implantation, ICD programing, education program, dronaderone, ivabradineB - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Abbott, Johnson & Johnson, Medtronic, : Xience V stent, education program

Montalescot Gilles Yes

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - consulting or lecture fees : xy - Bayer - consulting or lecture fees : xy

- Boehringer Ingelheim - consulting or lecture fees : xy

- Cardiovascular Research Foundation - consulting or lecture fees : xy

- Cleveland Clinic Research Foundation - consulting or lecture fees : xy

- Daiichi Sankyo - consulting or lecture fees : xy

- Duke Institute - consulting or lecture fees : xy

- Eli Lilly - consulting or lecture fees : xy

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Montalescot Gilles Yes - Europa - consulting or lecture fees : xy

- Lead-Up - consulting or lecture fees : xy

- GSK - consulting or lecture fees : xy

- Institut de Cardiologie de Montreal - consulting or lecture fees : xy

- Menarini - consulting or lecture fees : xy

- Nanospheres - consulting or lecture fees : xy

- Novartis - consulting or lecture fees : xy

- Pfizer - consulting or lecture fees : xy

- Portola - consulting or lecture fees : xy

- Sanofi Aventis - consulting or lecture fees : xy

- The Medicines Company - consulting or lecture fees : xy

- TIMI study group - consulting or lecture fees : xy

D - Research funding (departmental or institutional). - Astra Zeneca : xy - BMS : xy

- Boston Scientific : xy

- Eli Lilly : xy

- Medtronic : xy

- Pfizer : xy

- Servier : xy

- Sanofi Aventis : xy

- Abbott Vascular : xy

- Cordis : xy

- Fédération Française de Cardiologie : xy

- Fondation de France : xy

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Montalescot Gilles Yes - Guerbet Medical : xy

- INSERM : xy

- ITC Edison : xy

- Société Française de Cardiologie : xy

- Stago : xy

Neumann Franz Josef Yes

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Boston Scientific : devices - Medtronic : devices

- Cordis : devices

- Biotronic : devices

- Astra Zeneca : drugs

- The Medicines Company : drugs

- Lilly : drugs

- Siemens Healthcare : equipment

D - Research funding (departmental or institutional). - Boston Scientific : devices - Cordis : devices

- Metronic : devices

- Lilly : drugs

Neyses Ludwig Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier - speaker fees; investigator fees : Ivabradine D - Research funding (departmental or institutional). - Johnson & Johnson : Diagnostic use of metabolomics

Perk Joep Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca - speaker fees : None specific

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Perk Joep Yes B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Astra Zeneca : None specific

Pfisterer Matthias No

Roffi Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Eli Lilly Lilly/Daiichi Sankyo - speakers fees; advisory board fees (prasugrel) : Antiplatelet therapy D - Research funding (departmental or institutional). - Abbott : devices - Boston Scientific : devices

- Cordis and Medtronic : devices

- Biotronik : devices

Romeo Francesco No

Ruda Mikhail Ya No

Swahn Eva Yes

D - Research funding (departmental or institutional). - Schering-Plough : Phase III study (TRACER)

Tavares Aguiar Carlos Manuel

Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Merck Sharp & Dohme - speaker fees : Niacin/Laropiprant - Menarini - speaker fees : Olmesartan

- Servier - speaker fees; investigator fees : Perindopril/Indapamide, Ivabradine

- Lilly - consultancy fees : Prasugrel

- Bayer - speaker fees; advisory board fees (rivaroxaban) : Rivaroxaban, Nifedipine, Telmisartan, Aspirin

- Astra Zeneca - speaker fees : Rosuvastatin

- Boehringer Ingelheim - speaker fees : Telmisartan

- Bial Portela - speaker fees : Valsartan/Amlodipine

Valgimigli Marco Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - The Medicines Company : bivalirudin - Terumo : Interventional cardiology

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Valgimigli Marco Yes - Abbott Laboratories : ngal

- Accumetrics : Platlet Function Assay

- Roche Pharma : PPAR alpha/gamma

- Medtronic : stent

- Abbott Vascular : stent

- Cordis : stent

- CID : stent

- Astra Zeneca - consulting or lecture fees : ticagrelor

- Chiesi Pharma : tirofiban

- Iroko Cardio : Tirofiban

D - Research funding (departmental or institutional). - Abbott Laboratories : ngal

Vrints Christian Joseph Marie

Yes

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Bayer : pharma D - Research funding (departmental or institutional). - Abbott : interventional cardiology - Medtronic : pacing

Widimsky Petr Yes A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc. - Servier : Antiischemic agents - Astra Zeneca : Antithrombotic agents

- Bayer : Antithrombotic agents

- Boehringer-Ingelheim : Antithrombotic agents

- Daiichi Sankyo : Antithrombotic agents

- Eli Lilly : Antithrombotic agents

- The Medicines Company : Antithrombotic agents

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

Widimsky Petr Yes - Duke University : Antithrombotic agents

- Abbott : Stents

- Boston Scientific : Stents

- Medtronic : Stents

Guidelines on ACS-NSTE (TF21) - Document Reviewers

Expert Relationship with Industry

Type of relationship with industry Financial declaration

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesAuricchio Angelo

- Biologics Delivery Systems, Cordis Corporation a Johnson & Johnson company : Biological Therapy

- Philips : Cardiac Imaging

- Merck : Drugs

- Biotronik : Implantable Cardiac Electronic Device

- EBR Systems : Implantable Cardiac Electronic Device

- Impulse Dynamics : Implantable Cardiac Electronic Device

- Medtronic : Implantable Cardiac Electronic Device

- Sorin : Implantable Cardiac Electronic Device

- St. Jude Medical : Implantable Cardiac Electronic Device

- Abbott : Implantable Cardiac Electronic Device

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBaumgartner Helmut

- Actelion : Bosentan for PAH treatment in congenital heart disease

- AGA : Devices for catheter treatment of congenital heart defects

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.

- Edwards Lifesciences : transcatheter valve implantation

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesBax Jeroen

- Heart.org : Education

- Servier : Farma

- Astra Zeneca : Farma

- GE Healthcare : Imaging

- Lantheus : Imaging

- Philips : Imaging

- St Jude Medical : Pacing

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

- Medtronic : Pacing

- Impulse Dynamics : Pacing

- Biotronik : Pacing

- Boston Scientific : Pacing

D - Research funding (departmental or institutional).YesBax Jeroen

- Servier : Farma

- Edwards Lifesciences : Heart Valves

- Lantheus : Imaging

- GE Healthcare : Imaging

- Boston Scientific : Pacing

- Medtronic : Pacing

- St Jude Medical : Pacing

- Biotronik : Pacing

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesCeconi Claudio

- Servier : Pharmaceutical

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesDeaton M Christi

- St Jude Ltd : Cath lab - speaker X 1

- Daiichi Sankyo : consultant for patient adherence 2009-10

- Eli Lilly : consultant for patient adherence 2009-10

D - Research funding (departmental or institutional).

- Novo Nordisk : medicines for diabetes

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFagard Robert

- Servier : perindopril; support for organisation of scientific meeting

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesFunck-Brentano Christian

- Pierre-Fabre : Cardiac Safety of non-cardiovasclar products

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

- Servier : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.

- Johnson & Johnson : Cardiac safety of non-cardiovascular drugs under development or on the market. Design of phase I/II trials.

- Sigma-Tau (Italy) : Cardiac Saftey of an antimalarial drug

- Santhera (CH) : Cardiac Saftey of an antimalarial drug

- MMV (CH) : Cardiac Saftey of an antimalarial drug

- TROPHOS : DSMB for an investigational drug in Amyotrophic Lateral Sclerosis – Cardiac safety

- CEPHALON : DSMB in an oncology phase IIb trial

- Jansen-Cilag : Proton-pump inhibitors and drug interactions, including Clopidogrel

D - Research funding (departmental or institutional).YesFunck-Brentano Christian

- Jansen-Cilag : Proton-pump inhibitors and drug interactions with Clopidogrel

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesHasdai David

- Sanofi Aventis : Enoxaparin

D - Research funding (departmental or institutional).YesHoes Arno

- Bayer Healthcare : unresctricted grant for diagnostic kits in suspected cardiovascualar disease

- Abbott Laboratories : unresctricted grant for diagnostic kits in suspected cardiovascualar disease

- Roche : unresctricted grant for diagnostic kits in suspected heart failure and acute coronary syndrome

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKnuuti Juhani

- Lantheus Inc : Imaging tracers

D - Research funding (departmental or institutional).

- Bayer : Development of imaging agents

- GE Healthcare : Development of imaging agents

- Lantheus : Development of imaging agents

- Novartis : Development of imaging agents

- Roche : Drugs for brain diseases

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

- Merck Sharp & Dohme : Antiarrhythmic agents

- Bristol Myers Squibb : Antiplatelet agents

- Astra Zeneca : Antiplatelet agents

- Regado Biosciences : Antithrombotic agents

- Abbott - lecture fees : coronary stents

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesKolh Philippe H

- Merck Sharp & Dohme : Antistaphylococcic vaccine

D - Research funding (departmental or institutional).

- Edwards Lifesciences : Cardiac valves

- Medtronic : Cardiac valves

- St Jude Medical : Cardiac valves

- Siemens Healthcare : Imaging

- Johnson & Johnson : Thoracoscopic devices

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesMcDonagh Theresa

- Vifor International : Ferrinject

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.

- Servier - speaker fee : Ivabridine

D - Research funding (departmental or institutional).

- Biotronik - Clinical Trial : CRT

D - Research funding (departmental or institutional).YesPoldermans Don

- Maquette : Balloon pump device

- Merck : drugs

- Novartis : drugs

- Baxter : drugs

- Medtronic : Reveal device

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesPopescu Bogdan Alexandru

- GE Healthcare : Imaging

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesReiner Zeljko

- Bayer Healthcare : anticoagulants

- Abbott - lecture fees : antilipemics

- Astra Zeneca : antilipemics

- Merck Sharp & Dohme : antilipemics

- Pfizer : antilipemics

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesSechtem Udo

- Boehringer Ingelheim : Anticoagulation

- Daiichi Sankyo : Antiplatelet therapy

- Novartis : Drugs

- General Electric : Imaging

- Siemens Healthcare : Imaging

B - Payment to your Institution: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.

- Novartis : Imaging devices

- Johnson & Johnson : Stents

D - Research funding (departmental or institutional).YesSirnes Per Anton

- Bayer : clinical studies atrial fibrillation investigator fee

- Johnson & Johnson : inestigator fee, ckinical study, atrial fibrillation

- MSD : investgator fee clinical studies hyperlipidemia, SCAD

- Glaxo Smith Kline : investigator fee, clinical study , SCAD

- Servier : investigator fee, clinical study, coronary artery disease

- Jansen-Cilag : investigator fee, clinical study, diabetes CVD

- Boehringer Ingelheim : investigator fee, clinicla study, AF

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesTorbicki Adam

- Boehringer-Ingelheim : anticoagulation

- Sanofi Aventis : anticoagulation

- Pfizer : anticoagulation, pulmonary hypertension

- Lilly : pulmonary hypertension

- Actelion : pulmonary hypertension

- Bayer Healthcare : pulmonary hypertension, anticoagulation

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesVahanian Alec

- Boehringer Ingelheim : Valve prostheses

- Siemens Healthcare : Valve prostheses

- Valtech : Valve prostheses

- Edwards Lifesciences : Valve prostheses

- Abbott : Valve prostheses

- Medtronic - Advisory Board : Valve prostheses

A - Direct Personal payment: Speaker fees, Honoraria, Consultancy, Advisory Board fees, Investigator, Committee Member, etc.YesWindecker Stephan

- Astra Zeneca : Antiplatelet drug

- Eli Lilly : Antiplatelet drug

- Abbott : Stent

- Biosensors : Stent

- Biotronik : Stent

- Boston Scientific : Stent

- Cordis : Stent

- Medtronic : Stent

D - Research funding (departmental or institutional).

- Medtronic : Stent

ESC Committee for Practice Guidelines 2010-2012

ExpertRelationship

with IndustryType of relationship with industry Financial declaration

- Abbott : Stent

- Biosensors : Stent

- Cordis : Stent

This table represents the relevant relationships of the above experts with Industry and other entities that were reported to us at the time of publication of the guidelines.


Recommended